-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II

Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Imran Ahmad, MD1, Samia Harbi, MD2*, Raynier Devillier, MD, PhD2*, Cristina Castilla-Llorente, MD3*, Marie Robin, MD, PhD4*, Micha Srour5*, Jacques-Olivier Bay, MD, PhD6*, Patrice Ceballos, MD7*, Stéphanie Nguyen-Quoc, MD, PhD8*, Édouard Forcade9*, Claude-Éric Bulabois, MD10*, Amandine Charbonnier, MD11*, Pascal Turlure, MD12*, Sylvain Chantepie, MD13*, Sébastien Maury14*, Michael Loschi, MD15*, Hélène Labussière-Wallet16*, Tony Marchand, MD, PhD17*, Marianne Schwarz, MD18*, Ambroise Marçais, MD, PhD19*, Ana Berceanu, MD20*, Étienne Daguindau, MD20*, Patrice Chevallier, MD21, Anne Huynh, MD22*, Mohamad Mohty, MD, PhD23, Remy Dulery, MD, PhD24*, Johan Maertens, MD, PhD25*, Xavier Poiré, MD, PhD26*, Natacha Maillard, MD27*, Marie-Thérèse Rubio, MD, PhD28*, Gaëlle Guillerm, MD29*, Yves Chalandon, MD30, Anne-Lise Ménard31* and Jérôme Cornillon, MD32*

1Hôpital Maisonneuve-Rosemont, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
2Hematology and Transplantation, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France
3Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
4Department of Hematology, Transplantation Division, Hopital Saint-Louis, Paris Cedex 10, France
5CHU de Lille, Lille, France
6Service d’hématologie, CHU Clermont-Ferrand, Clermont-Ferrand, France
7Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
8Service d'hématologie clinique, Hôpital de la Pitié-Salpêtrière AP-HP, Paris, France
9Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Pessac, France
10Hématologie Soins Intensifs, CHU Grenoble Alpes, Grenoble, France
11Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
12Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
13Institut d'Hématologie, CHU de Caen, Caen, France
14Hematology Department, Hôpitaux universitaires Henri Mondor AP-HP & Université Paris Est Créteil, Créteil, France
15Service d’hématologie, CHU de Nice, Nice, France
16Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
17INSERM U1236, Université Rennes 1, Rennes, France
18Centre Hospitalier Universitaire d’Angers, Angers, France
19Department of Hematology, Institut Imagine, Necker Hospital, Paris Descartes University, Paris, France
20Department of Clinical Hematology, CHU de Besançon, Besançon, France
21Service d'hématologie, CHU de Nantes, Nantes, France
22Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
23Saint-Antoine Hospital, Sorbonne University, Paris, France
24INSERM UMRs 938, Sorbonne University, Centre de Recherche Saint-Antoine (CRSA), Paris, France
25Department of Hematology, University Hospitals Leuven, Leuven, Belgium
26Section of hematology, Institut Roi Albert II, Cliniques Universitaires St-Luc, Brussels, Belgium
27Hematology Department, CHU de Poitiers, Poitiers, France
28Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandoeuvre-les-Nancy, France
29Service d'hématologie, Hôpital Morvan, CHRU Brest, Brest, France
30Univ. Hospital of Geneva, Geneva, Switzerland
31Département d'hématologie clinique, Centre Henri-Becquerel, Rouen, France
32Département d’hématologie clinique et de thérapie cellulaire, CHU de St-Étienne, Saint-Étienne, France

Deborah Christen, MD1,2,3*, Johannes Luebke, MD3,4*, Anne Kaiser, MD1,2*, Juliana Schwaab4*, Khalid Shoumariyeh, MD5,6*, Madlen Jentzsch7*, Katja Sockel, MD8*, Judith Schaffrath, MD9*, Francis A. Ayuk, MD10*, Matthias Stelljes, MD11, Inken Hilgendorf, MD12*, Elisa Sala, MD13*, Jennifer Kaivers, MD14*, Stefan Schönland, MD15*, Christoph Wittke, MD16*, Bernd Hertenstein, MD17*, Markus P. Radsak18*, Ulrich Kaiser19*, Valeska Brückl, MD20*, Nicolaus Kröger, MD21*, Stefan Klein, MD4, Wolf-Karsten Hofmann, MD4*, Tim H. Brümmendorf1,2, Edgar Jost, MD1,2*, Jens Panse, MD1,2,3 and Andreas Reiter, MD3,4

1Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
2Center for Integrated Oncology - Aachen Bonn Cologne Duesseldorf (CIO-ABCD), Aachen, Germany
3contributed equally, ., Germany
4Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
5Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany
6German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany
7Medical Clinic and Policlinic 1, for Hematology and Cellular Therapy, University of Leipzig Medical Center, Leipzig, Germany
8Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
9Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
10Department of Stem Cell Transplantation with Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
11Department of Medicine A/Hematology and Oncology, University of Muenster, Münster, Germany
12Universitätsklinikum Jena, Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Jena, Germany
13Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
14Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
15Department of Internal Medicine V, Division of Hematology/Oncology/Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
16Department of Medicine, Clinic III, Hematology, Oncology and Palliative Medicine, Rostock University Medical Center, Rostock, Germany
17Klinikum Bremen-Mitte, Bremen, Germany
183rd Department of Medicine, Johannes Gutenberg University Medical Center, Mainz, Germany
19Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
20Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
21Department of Stem Cell Transplantation with Research Department Cell and Gene Therapy University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Yasutaka Sadaga1*, Yuho Najima, MD, PhD2, Takayoshi Tachibana, MD, PhD3*, Kaito Harada, MD, PhD4*, Takuya Miyazaki, MD, PhD5*, Takashi Toya, MD, PhD6*, Masatsugu Tanaka, M.D., Ph.D.3*, Yukiko Misaki, MD7*, Hiroki Yokoyama, MD, PhD8*, Shinichiro Fujiwara, MD, PhD9*, Emiko Sakaida, MD, PhD10, Nobuyuki Aotsuka, MD, PhD11*, Satoshi Takahashi12, Akira Yokota, MD, PhD13*, Hiroaki Shimizu, MD, PhD6, Shinichi Kako, MD, PhD7, Shingo Yano, MD, PhD8, Takeshi Kobayashi, MD, PhD6*, Noriko Doki, MD, PhD6 and Yoshinobu Kanda7,9*

1Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, TKY, Japan
2Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, TKY, Japan
3Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
4Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan
5Department of Hematology, Yokohama City University Medical Center, Kanagawa, Japan
6Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
7Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
8Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
9Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
10Department of Hematology, Chiba University Hospital, Chiba City, Japan
11Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan
12Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
13Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan

Masashi Nishikubo, MD1*, Yoshimitsu Shimomura2*, Yosuke Nakaya3*, Akihito Shinohara4*, Naoyuki Uchida, MD, PhD5, Nobuyuki Takayama, MD, PhD6, Hikaru Kobayashi7*, Yasufumi Uehara8*, Jun Ishikawa9*, Kazuya Ishiwata, M.D., Ph.D.10*, Nobuhiro Hiramoto2*, Hideyuki Nakazawa, MD, PhD11*, Fumihiko Ishimaru12*, Takahiro Fukuda, MD, PhD13*, Yoshinobu Kanda14*, Yoshiko Atsuta, MD, PhD15*, Eisei Kondo, MD, PhD16* and Shinichi Kako, MD, PhD14

1Department of Hematology, Kobe City Medical Center General Hospital, Kobe, HYO, Japan
2Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
3Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
4Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan
5Department of Hematology, Toranomon Hospital, Tokyo, Japan
6Department of Hematology, Kyorin University Faculty of Medicine, Mitaka, Japan
7Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan
8Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
9Department of Hematology, Osaka International Cancer Institute, Osaka, Japan
10Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan
11Department of Hematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan
12Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan
13Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
14Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
15Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
16Department of Hematology, Kawasaki Medical School, Kurashiki, Japan

Mary-Elizabeth M. Percival, MD1,2, Ted Gooley, PhD3*, Chris Davis1*, Ryan S. Basom1*, Stephanie J. Lee2,4, Frederick R. Appelbaum, MD4,5 and Mohamed Sorror, MD, MSc4,6

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA
4Fred Hutchinson Cancer Center, Seattle, WA
5Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
6University of Washington School of Medicine, Seattle, WA

Shunto Kawamura, MD1*, Masaharu Tamaki2*, Takaaki Konuma3*, Makoto Onizuka, MD, PhD4, Emiko Sakaida, MD, PhD5, Hiromi Hayashi6*, Noriko Doki, MD, PhD7, Tetsuya Nishida, MD, PhD8*, Masashi Sawa, MD, PhD9*, Hiroyuki Ohigashi10*, Takahiro Fukuda, MD, PhD11*, Jun Ishikawa12*, Ken-ichi Matsuoka, MD, PhD13*, Toshiro Kawakita, MD, PhD14*, Masatsugu Tanaka, M.D., Ph.D.15*, Fumihiko Ishimaru, MD, PhD16, Tatsuo Ichinohe, MD17, Yoshiko Atsuta, MD, PhD18,19*, Yoshinobu Kanda2,20*, Kimikazu Yakushijin, MD, PhD21, Junya Kanda22 and Hideki Nakasone, MD, PhD2,23

1Division of Hematology, Jichi Medical University Saitama Medical Center, Minuma-Ku Saitama-Shi, Saitama, Japan
2Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
3Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
5Department of Hematology, Chiba University Hospital, Chiba City, Japan
6Graduate School of Medicine, Kyoto University, Kyoto, JPN
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
9Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
10Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
11Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
12Department of Hematology, Osaka International Cancer Institute, Osaka, Japan
13Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
14Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
15Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
16Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan
17Department of Hematology and Oncology, Research Institute For Radiation Biology and Medicine, Hiroshima, Japan
18Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
19Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
20Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
21Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
22Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
23Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan

Ann-Kristin Schmälter, MD1*, Myriam Labopin2*, Jurjen Versluis, MD, PhD3*, Maria Pilar Gallego Hernanz, MD4*, Matthias Eder5*, Peter A. Von Dem Borne, MD, PhD6*, Gerard Socié7, Patrice Chevallier, MD8, Edouard Forcade, MD, PhD9*, Andreas Neubauer, MD10, Frederic Baron, MD, PhD11, Ali Bazarbachi, MD, PhD12, Gesine Bug, MD13*, Arnon Nagler14*, Christoph Schmid, MD1*, Jordi Esteve, MD, PhD15, Fabio Ciceri16* and Mohamad Mohty, MD, PhD17,18

1Section for Stem Cell Transplantation, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, Netherlands
4Hematology Department, CHU de Poitiers, Poitiers, France
5Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
6Hematology, Leiden University Medical Center, Leiden, Netherlands
7Hopital St. Louis, Department of Hematology - BMT, Paris, France
8CHU De NANTES, Nantes Cedex 1, France
9Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Pessac, France
10Department of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany, Marburg, Germany
11CHU of Liege and University of Liege, Liege, Belgium
12American University of Beirut Dept. of Medicine, Beirut, Lebanon
13Dept. of Medicine 2, Goethe University, University Hospital, Frankfurt, Germany
14Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
15Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain
16Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
17Department of Haematology, Saint Antoine Hospital, Paris, France
18Department of Hematology and Cell Therapy, EBMT Paris study office, Saint Antoine Hospital, Paris, France

Xingyu Cao1,2*, Jianping Zhang1,2*, Yue Lu, PhD1,2*, Yanli Zhao1,2*, Deyan Liu1,2*, Min Xiong1,2*, Ruijuan Sun1,2*, Zhijie Wei1,2*, Jiarui Zhou1,2*, Xian Zhang, MD2,3*, Junfang Yang1,2*, Hongxing Liu Sr., MD1,2,4 and Peihua Lu, MD2,3,5*

1Hebei Yanda Lu Daopei Hospital, Langfang, China
2Beijing Lu Daopei Hospital, Beijing, China
3Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China
4Beijing Lu Daopei Institute of Hematology, Beijing, China
5Beijing Lu Daopei Institute of Hematology, Langfang, China

Asmita Shukla, MD1*, Seongho Kim2*, Hyejeong Jang3*, Andrew Kin, MD4, Aasiya Matin, MD5, Lois Ayash, MD5, Abhinav Deol, MD6*, Voravit Ratanatharathorn, MD5, Joseph Uberti, MD, PhD5 and Dipenkumar Modi, MD3

1Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI
2Karmanos Cancer Institue/Wayne State University, Detroit, MI
3Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
4Karmanos Cancer Institute/Wayne State University, DETROIT, MI
5Karmanos Cancer Institute/Wayne State University, Detroit, MI
6Karmanos Cancer Institute/ Department of Oncology, Wayne State University, Detroit, MI

Ming Jiang1,2*, Hailong Yuan1*, Jianli Xu1*, Jianhua Qu, MD1*, Gang Chen1*, Nannan Pang1*, Hongbo Wang1*, Kaile Zhang1*, Linglu Ding1*, Xiaojuan Bi2*, Wenyan Miao1* and Le Zhang1*

1Hematology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
2The State Key Laboratory of Pathogenesis and Prevention of Central Asian High Incidence Diseases, Urumqi, China

Moazzam Shahzad, MD1,2, Muhammad Fareed Khalid, MD3*, Atif Butt, MD4*, Huda Fatima, MD, MBBS5*, Junaid Khan, MD6*, Mohammad Ammad Ud Din, MBBS1,2, Iqra Anwar, MBBS7*, Muhammad Kashif Amin, MD7*, Qamar Iqbal, MD8* and Michael V. Jaglal, MD9

1University of South Florida, Tampa, FL
2H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Danbury Hospital, Danbury, CT, Danbury, CT
4St. Mary’s Medical Center, Huntington, WV, Huntington, WV
5Mercy Health St. Vincent Medical Center, Toledo, OH
6TidalHealth, Salisbury, MD
7University of Kansas Medical Center, Kansas City, KS
8Hospitalist, TidalHealth, Salisbury, MD
9Department of Hematology/Oncology, Moffitt Cancer Center, Tampa, FL

Chengjuan Luo1*, Yanjing Tang2*, Changying Luo3*, Xiaohang Huang3*, Xia Qin3*, Hua Zhu3*, Benshang Li, MD, PhD4* and Jing Chen, MD, PhD4*

1Department of Hematology and Oncology, Shanghai Children’s Medical Center of Shanghai Children’s Medical Center affiliated to Shanghai Jiaotong University Medical School, Shanghai, China
2Shanghai Children's Medical Center, Shanghai, China
3Department of Hematology and Oncology, Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
4Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Simon M. Krauß1*, Tara Holloway1*, Lara Bischof1*, Donata Backhaus, MD1*, Dominic Brauer, MD1*, Jule Ussmann1*, Anne Weigert, PhD1*, Georg-Nikolaus Franke2*, Vladan Vucinic, M.D.2*, Uwe Platzbecker, MD3, Sebastian Schwind, MD1*, Madlen Jentzsch2* and Klaus H Metzeler, MD4

1Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
2Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
3Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
4Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany

Derya Koyun1*, Uğur Şahin2*, Güldane Cengiz Seval1*, Deniz Gören Şahin3*, Ayla Gökmen2*, Sinem Civriz Bozdağ1*, Selami Kocak Toprak1*, Pervin Topçuoğlu1*, Meltem Kurt Yüksel1*, Önder Arslan1*, Taner Demirer1*, Günhan Gürman1*, Osman İlhan1*, Meral Beksac, MD1, Muhit Özcan1* and Mutlu Arat3

1Ankara University School of Medicine, Hematology Department, Ankara, Turkey
2Medicana International Ankara Hospital, Hematology Department, Ankara, Turkey
3İstanbul Florence Nightingale Hospital, Hematology Department, İstanbul, Turkey

Stacey M Frumm, md1*, Haesook T. Kim, PhD2, Amar H Kelkar, MD3, Vincent T. Ho, MD4*, Mahasweta Gooptu, MD3, Christopher James Gibson, MD3, John Koreth, MD, MBBS, PhD, DPhil3, Roman M. Shapiro, MD3, Rizwan Romee, MD5, Sarah Nikiforow, MD, PhD3, Joseph H. Antin, MD6, Robert J. Soiffer, MD3, Benjamin Rolles, MD7, Shai Shimony, MD8*, Jan Philipp Bewersdorf, MD9, Tariq Kewan, MBBChir10, Abdulrahman Alhajahjeh, MD11*, Marlise R. Luskin, MD4, Jacqueline S. Garcia, MD8, Evan C. Chen, MD3, Andrew A. Lane, MD, PhD12, Martha Wadleigh, MD3, Eric S. Winer, MD3, Richard M Stone, MD3, Daniel J. DeAngelo3, Amer M. Zeidan, MBBS, MHS13, Coleman Lindsley, MD, PhD3, Corey Cutler3 and Maximilian Stahl, MD4

1Brigham and Women's Hospital, Brookline, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Dana-Farber Cancer Institute, Boston, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Dana Farber Cancer Institute, Boston, MA
6Dana-Farber Cancer Inst. Brigham & Women's Hospital, Boston, MA
7Division of Hematology, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
8Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
9Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
11University of Jordan, Amman, Jordan
12Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
13Section of Hematology, Department of Internal Medicine, Yale University School of Medicine - Yale Cancer Center, New Haven, CT

Chen Liang1*, Aiming Pang2*, Yi He3*, Donglin Yang3*, Rongli Zhang3*, Qiaoling MA3*, Mingzhe Han3*, Sizhou Feng2* and Erlie Jiang, PhD3

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2National Key Laboratory of Blood Science, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Yang Cao1*, Wenxuan Huo2*, Yang Yang, MD1*, Jiayu Huang3*, Yu Wang, MD4*, Liang Huang5, Yingjun Chang6*, Xiaoxia Hu3* and Xiaodong Mo2*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, Wuhan, China
2Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China., Beijing, China
3State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China, Shanghai, China
4Peking University People’s Hospital, Beijing, China
5Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China
6Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Ronald Sobecks, MD1, Hong Li, MS2*, Danielle Cenin, PharmD3*, Seema Patel, PharmD3*, Jesse Edwards, PharmD3*, Stephanie Farlow, BS4*, Amelia Bragg4*, Rabi Hanna, MD5, Seth J Rotz, MD5*, Deepa Jagadeesh, MD6, Aaron T. Gerds, MD, MS4, Robert M. Dean, MD7, Brad Pohlman, MD7, Betty K. Hamilton, MD8, Claudio Brunstein, MD, PhD7, Matt Kalaycio, MD7 and Craig S Sauter, MD7

1Blood and Marrow Transplant, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic, Cleveland
3Cleveland Clinic, Cleveland
4Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
5Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH
6Cleveland Clinic, Cleveland, OH
7Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
8Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Maxime Jullien, MD1*, Baptiste Le Calvez2*, Amandine Le Bourgeois3*, Thierry Guillaume, MD, PhD3*, Pierre Peterlin4*, Alice Garnier, MD5* and Patrice Chevallier, MD4

1Nantes University Hospital, NANTES, France
2Nantes University, Inserm UMR 1307, CNRS UMR 6075, Angers University, CRCI2NA, Nantes - France, Nantes, France
3Nantes University Hospital, Nantes, FRA
4Nantes University Hospital, Nantes, France
5Hematology clinic, Nantes University Hospital, Nantes, France

*signifies non-member of ASH